These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9364674)

  • 1. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.
    Leroux-Roels G; Desombere I; De Tollenaere G; Petit MA; Desmons P; Hauser P; Delem A; De Grave D; Safary A
    Vaccine; 1997 Nov; 15(16):1724-31. PubMed ID: 9364674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.
    Leroux-Roels G; Desombere I; Cobbaut L; Petit MA; Desmons P; Hauser P; Delem A; De Grave D; Safary A
    Vaccine; 1997 Nov; 15(16):1732-6. PubMed ID: 9364675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
    Eyigün CP; Yilmaz S; Gül C; Sengül A; Hacibektasoglu A; Van Thiel DH
    J Viral Hepat; 1998 Jul; 5(4):265-9. PubMed ID: 9751013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B vaccine.
    Madaliński K; Sylvan SP; Hellstrom U; Mikołajewicz J; Dzierzanowska-Fangrat K
    Med Sci Monit; 2004 Jan; 10(1):PI10-7. PubMed ID: 14704645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus vaccination for older adults.
    Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
    J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac vaccine and their relation to the antibody response to hepatitis B surface antigen.
    Hellström UB; Madalinski K; Sylvan SP
    Virol J; 2009 Jan; 6():7. PubMed ID: 19154574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.
    Rendi-Wagner P; Shouval D; Genton B; Lurie Y; Rümke H; Boland G; Cerny A; Heim M; Bach D; Schroeder M; Kollaritsch H
    Vaccine; 2006 Apr; 24(15):2781-9. PubMed ID: 16455169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
    Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
    Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to preS components after immunization of children with low doses of BioHepB.
    Madalinski K; Sylvan SP; Hellström U; Mikolajewicz J; Zembrzuska-Sadkowska E; Piontek E
    Vaccine; 2001 Oct; 20(1-2):92-7. PubMed ID: 11567751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous expression of modified hepatitis B surface antigen fusion polypeptides containing preS1, preS2 epitopes in Pichia pastoris].
    Tan CY; Jiang LM; Ge YH; Yuan J; Jin O; Hu B
    Sheng Wu Gong Cheng Xue Bao; 2006 Jul; 22(4):604-8. PubMed ID: 16894895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-preS responses influence the anti-HBs response in newborns after vaccination with the third generation Sci-B-Vac vaccine.
    Sylvan SP; Madalinski K; Hellström UB
    Vaccine; 2009 Dec; 28(2):446-51. PubMed ID: 19874926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and immunogenicity of a Pichia pastoris-derived hepatitis B vaccine containing preS1, preS2 and S epitopes].
    Tan CY; Yuan J; Jin O; Jiang LM; Hu B
    Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):700-3. PubMed ID: 17822047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products.
    Pride MW; Bailey CR; Muchmore E; Thanavala Y
    Vaccine; 1998 Apr; 16(6):543-50. PubMed ID: 9569463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
    Raz R; Koren R; Bass D
    Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
    Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
    Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
    Toita R; Kawano T; Kang JH; Murata M
    World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
    Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.